83.33 USD
↗ 1.94 (2.38%)AT CLOSE (03:59 PM EST)
DexCom, Inc.
DXCMNASDAQ • USD
82.65
↘ 0.68 (0.82%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
82.65
↘ 0.68 (0.82%)
Market: CLOSED
DexCom, Inc. (DXCM) trades at $83.33 per share. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". This is driven by a robust Altman Z-Score, exceptional Return on Equity (39.1%) and a bullish Golden Cross on the moving averages. On the valuation front, DXCM trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Nov 13, 2026.
Open?$82.01
High?$83.66
Low?$81.39
Prev. Close?$81.39
Volume?3.0M
Avg. Volume?4.5M
VWAP?$82.76
Rel. Volume?0.67x
Bid / Ask
Bid?$82.00 × 4.6K
Ask?$83.30 × 200
Spread?$1.30
Midpoint?$82.65
Valuation & Ratios
Market Cap?31.1B
Shares Out?373.0M
Float?375.9M
Float %?99.6%
P/E Ratio?31.36
P/B Ratio?12.26
EPS?$2.66
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
Themes
Employees
11.1K
Market Cap
31.1B
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
Listed
2005-04-14
Address
6340 SEQUENCE DRIVE
SAN DIEGO, CA 92121
Phone: (858) 200-0200
SAN DIEGO, CA 92121
Phone: (858) 200-0200
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?100
Momentum?80
Short Sent.?75
Piotroski F-Score?4/9Mixed
Altman Z-Score?7.53Safe
Confidence?66%Moderate
Short InterestLow
Short % of Float?4.24%Low
Short Interest?15.9M
Days to Cover?2.8
Free Float375.9M
Avg Daily Volume5.7M
Settlement Date2026-10-30
Financial Health
Current Ratio?1.74Adequate
Quick Ratio?1.40Adequate
Cash Ratio?0.43Low
Debt/Equity?0.49Low
ValuationRICHLY VALUEDvs 5 peers + S&P 500
Score44/100
P/E?31.4PRICEY▾
Peers67
S&P30
P/B?12.26HIGH▾
Peers17
S&P16
P/S?6.09FAIR▾
Peers33
S&P21
P/FCF?28.3FAIR▾
Peers50
S&P32
EV/EBITDA?20.9HIGH▾
Peers17
S&P23
EV/Sales?6.14HIGH▾
Peers33
S&P27
Returns & Efficiency
ROE?39.1%STRONG▾
Peers100
S&P87
ROA?15.9%STRONG▾
Peers100
S&P89
Cash Flow & Enterprise
FCF?$1.1B
Enterprise Value?$31.4B
Fundamentals ratios updated end of day